24 In this review, we discuss the benefits and challenges associated with the small-molecule GLP-1 RA drugs from pre-clinical and clinical studies
The affinity profile is calibrated for triple balance: full agonist at GIPR, full agonist at GLP-1R, partial agonist at GCGR, preserving glycemia while exploiting glucagon thermogenic benefits
Central GLP-1 neurones in the brainstem react to stomach distension and meal consumption, conveying satiety signals
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
The effects of calorie restriction on autophagy: role on aging intervention
Or is the development of obesity rooted in a far deeper set of psychological issues including depression, anxiety, self-esteem or pain